Consent Through Rose-Tinted Glasses: The Optimistic Bias in Parkinson's Disease Clinical Trials

&
American Journal of Bioethics Neuroscience 6 (1):63-64 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2014.995322

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,654

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Informed consent in emergency research: A contradiction in terms.Malcolm G. Booth - 2007 - Science and Engineering Ethics 13 (3):351-359.
Involvement and (Potential) Influence of Care Providers in the Enlistment Phase of the Informed Consent Process: the case of aids clinical trials.Mary-Rose Mueller - 2004 - Nursing Ethics 11 (1):42-52.
Bias in recruitment to cluster randomized trials: a review of recent publications. [REVIEW]Gwen Brierley, Sally Brabyn, David Torgerson & Judith Watson - 2012 - Journal of Evaluation in Clinical Practice 18 (4):878-886.
Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls.R. L. Albin - 2002 - Journal of Medical Ethics 28 (5):322-325.
Potential Subjects’ Responses to an Ethics Questionnaire in a Phase I Study of Deep Brain Stimulation in Early Parkinson’s Disease.Stuart G. Finder, Mark J. Bliton, Chandler E. Gill, Thomas L. Davis, Peter E. Konrad & P. D. Charles - 2012 - Journal of Clinical Ethics 23 (3):207-216.
Regulatory Misconception Muddies the Ethical Waters: Challenges to a Qualitative Study.Kimberly M. Yee & Paul J. Ford - 2012 - Journal of Clinical Ethics 23 (3):217-220.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Informed consent in acute myocardial infarction research.Anne Gammelgaard - 2004 - Journal of Medicine and Philosophy 29 (4):417 – 434.
Informed consent for clinical trials of deep brain stimulation in psychiatric disease: challenges and implications for trial design: Table 1.Nir Lipsman, Peter Giacobbe, Mark Bernstein & Andres M. Lozano - 2012 - Journal of Medical Ethics 38 (2):107-111.
Losing the rose tinted glasses: neural substrates of unbiased belief updating in depression.Neil Garrett, Tali Sharot, Paul Faulkner, Christoph W. Korn, Jonathan P. Roiser & Raymond J. Dolan - 2014 - Frontiers in Human Neuroscience 8.
Informed consent and the use of placebo in poland: Ethical and legal aspects. [REVIEW]Prof Piotr Zaborowski & Adam Górski - 2004 - Science and Engineering Ethics 10 (1):167-178.
The factor structure of the SF‐36 in Parkinson's disease.Pauline Banks & Colin R. Martin - 2009 - Journal of Evaluation in Clinical Practice 15 (3):460-463.
Unrealistic optimism in early-phase oncology trials.Lynn A. Jansen, Paul S. Appelbaum, William Mp Klein, Neil D. Weinstein, William Cook, Jessica S. Fogel & Daniel P. Sulmasy - 2011 - IRB: Ethics & Human Research 33 (1):1.
Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease.Audrey R. Chapman - 2015 - American Journal of Bioethics Neuroscience 6 (1):65-66.

Analytics

Added to PP
2018-06-22

Downloads
14 (#1,008,331)

6 months
3 (#1,020,910)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Two concepts of therapeutic optimism.L. A. Jansen - 2011 - Journal of Medical Ethics 37 (9):563-566.

Add more references